Recombinant Human EGF
To Order Contact us: lieven@wlsolutions.be
Recombinant Human EGF |
||
| MBS7610736-005mg | 0.05mg | EUR 345 |
Recombinant Human EGF |
||
| MBS7610736-02mg | 0.2mg | EUR 635 |
Recombinant Human EGF |
||
| MBS7610736-1mg | 1mg | EUR 1800 |
Recombinant Human EGF |
||
| MBS7610736-5x1mg | 5x1mg | EUR 6955 |
RECOMBINANT HUMAN EGF |
||
| MBS232234-05mg | 0.5mg | EUR 510 |
RECOMBINANT HUMAN EGF |
||
| MBS232234-5x05mg | 5x0.5mg | EUR 2130 |
Recombinant Human EGF |
||
| MBS4159643-1mg | 1mg | EUR 355 |
Recombinant Human EGF |
||
| MBS4159643-5x1mg | 5x1mg | EUR 1345 |
Recombinant Human EGF |
||
| PH2034-.01 | 10ug | EUR 208 |
|
Description: Peptides & Proteins|Recombinant Proteins |
||
Recombinant Human EGF |
||
| PH2034-.1 | 10X10ug | EUR 496 |
|
Description: Peptides & Proteins|Recombinant Proteins |
||
EGF (human), (recombinant) |
||
| MBS565858-01mg | 0.1mg | EUR 310 |
EGF (human), (recombinant) |
||
| MBS565858-5x01mg | 5x0.1mg | EUR 1330 |
Recombinant Human EGF, 1-51a.a. |
||
| HEGFP-0502 | 100ug | Ask for price |
Recombinant Human EGF, 1-51a.a. |
||
| P1146-.1 | 100ug | EUR 102.4 |
|
Description: Peptides & Proteins|Recombinant Proteins |
||
Recombinant Human EGF, 1-51a.a. |
||
| P1146-.5 | 500ug | EUR 228.8 |
|
Description: Peptides & Proteins|Recombinant Proteins |
||
Recombinant Human EGF Protein |
||
| E40KMP1945 | 20ug | EUR 495 |
Recombinant Human EGF Protein |
||
| RP01556 | 500μg | EUR 65 |
Recombinant Human EGF Protein |
||
| RP01556LQ | 50μg | EUR 26 |
Recombinant Human EGF protein |
||
| CD01883-10ug | 10ug | EUR 47 |
|
Description: Recombinant Human Epidermal Growth Factor is produced by our E.coli expression system and the target gene encoding Asn971-Arg1023 is expressed. |
||
Recombinant Human EGF protein |
||
| CD01883-50ug | 50ug | EUR 118 |
|
Description: Recombinant Human Epidermal Growth Factor is produced by our E.coli expression system and the target gene encoding Asn971-Arg1023 is expressed. |
||
Recombinant Human EGF Protein |
||
| MBS9141715-002mg | 0.02mg | EUR 165 |
Recombinant Human EGF Protein |
||
| MBS9141715-005mg | 0.05mg | EUR 195 |
Recombinant Human EGF Protein |
||
| MBS9141715-01mg | 0.1mg | EUR 250 |
Recombinant Human EGF Protein |
||
| MBS9141715-5x01mg | 5x0.1mg | EUR 945 |
Recombinant Human EGF Protein |
||
| MBS8248963-001mg | 0.01mg | EUR 150 |
Recombinant Human EGF Protein |
||
| MBS8248963-005mg | 0.05mg | EUR 220 |
Recombinant Human EGF Protein |
||
| MBS8248963-05mg | 0.5mg | EUR 575 |
Recombinant Human EGF Protein |
||
| MBS8248963-5x05mg | 5x0.5mg | EUR 2485 |
Recombinant Human EGF protein |
||
| MBS1561268-005mg | 0.05mg | EUR 320 |
Recombinant Human EGF protein |
||
| MBS1561268-01mg | 0.1mg | EUR 410 |
Recombinant Human EGF protein |
||
| MBS1561268-5x01mg | 5x0.1mg | EUR 1520 |
Recombinant Human EGF Protein |
||
| RP00359 | 10mg | EUR 11.34 |
Recombinant Human EGF Protein |
||
| RP02346 | 100μg | EUR 205.47 |
Human EGF Recombinant Protein |
||
| 100-008 | 100 µg | EUR 47.25 |
|
Description: Epidermal growth factor (EGF) is the founding member of the EGF family that also includes TGFα, amphiregulin (AR), betacellulin (BTC), epiregulin (EPR), heparin-binding EGF-like growth factor (HBEGF), epigen, and the neuregulins (NRG) 1 through 6. Members of the EGF family share a structural motif, the EGF-like domain, which is characterized by three intra-molecular disulfide bonds that are formed by six similarly spaced conserved cysteine residues. All EGF family members are synthesized as type I transmembrane precursor proteins that may contain several EGF domains in the extracellular region. The mature proteins are released from the cell surface by regulated proteolysis. The 1207 amino acid (aa) human EGF precursor contains nine EGF domains and nine LDLR class B repeats. The mature protein consists of 53 aa and is generated by proteolytic excision of the EGF domain proximal to the transmembrane region. Mature human EGF shares 70% aa sequence identity with mature mouse and rat EGF. EGF is present in various body fluids, including blood, milk, urine, saliva, seminal fluid, pancreatic juice, cerebrospinal fluid, and amniotic fluid. Four ErbB (HER) family receptor tyrosine kinases including EGFR/ErbB1, ErbB2, ErbB3 and ErbB4, mediate responses to EGF family members. EGF binds ErbB1 and depending on the context, induces the formation of homodimers or heterodimers containing ErbB2. Biological activities ascribed to EGF include epithelial development, angiogenesis, inhibition of gastric acid secretion, fibroblast proliferation, and colony formation of epidermal cells in culture. |
||
Human EGF Recombinant Protein |
||
| 100-009 | 500 µg | EUR 99.75 |
|
Description: Epidermal growth factor (EGF) is the founding member of the EGF family that also includes TGFα, amphiregulin (AR), betacellulin (BTC), epiregulin (EPR), heparin-binding EGF-like growth factor (HBEGF), epigen, and the neuregulins (NRG) 1 through 6. Members of the EGF family share a structural motif, the EGF-like domain, which is characterized by three intra-molecular disulfide bonds that are formed by six similarly spaced conserved cysteine residues. All EGF family members are synthesized as type I transmembrane precursor proteins that may contain several EGF domains in the extracellular region. The mature proteins are released from the cell surface by regulated proteolysis. The 1207 amino acid (aa) human EGF precursor contains nine EGF domains and nine LDLR class B repeats. The mature protein consists of 53 aa and is generated by proteolytic excision of the EGF domain proximal to the transmembrane region. Mature human EGF shares 70% aa sequence identity with mature mouse and rat EGF. EGF is present in various body fluids, including blood, milk, urine, saliva, seminal fluid, pancreatic juice, cerebrospinal fluid, and amniotic fluid. Four ErbB (HER) family receptor tyrosine kinases including EGFR/ErbB1, ErbB2, ErbB3 and ErbB4, mediate responses to EGF family members. EGF binds ErbB1 and depending on the context, induces the formation of homodimers or heterodimers containing ErbB2. Biological activities ascribed to EGF include epithelial development, angiogenesis, inhibition of gastric acid secretion, fibroblast proliferation, and colony formation of epidermal cells in culture. |
||
Recombinant Human HB-EGF (Heparin Binding EGF) |
||
| Z102155 | 50 µg | EUR 85 |
|
Description: Human HBEGF (Heparin Binding EGF like growth factor) is a member of the EGF family of peptide growth factors that signal through the EGF receptor, and stimulates the proliferation of smooth muscle cells, fibroblasts, epithelial cells, and keratinocytes. HBEGF is expressed in many cell types and tissues, including bronchial epithelium, visceral and vascular smooth muscle, CD4+ T cells, glomerular podocytes, keratinocytes, macrophages and certain tumor cells. Mature HBEGF is a soluble peptide that arises from the proteolytic processing of the 208 amino acid type-I transmembrane form and exhibits the ability to specifically bind heparin and heparin sulfate proteoglycans. |
||
Recombinant Human HB-EGF (Heparin Binding EGF) |
||
| Z102157 | 200 µg | EUR 240 |
|
Description: Human HBEGF (Heparin Binding EGF like growth factor) is a member of the EGF family of peptide growth factors that signal through the EGF receptor, and stimulates the proliferation of smooth muscle cells, fibroblasts, epithelial cells, and keratinocytes. HBEGF is expressed in many cell types and tissues, including bronchial epithelium, visceral and vascular smooth muscle, CD4+ T cells, glomerular podocytes, keratinocytes, macrophages and certain tumor cells. Mature HBEGF is a soluble peptide that arises from the proteolytic processing of the 208 amino acid type-I transmembrane form and exhibits the ability to specifically bind heparin and heparin sulfate proteoglycans. |
||
Recombinant Human HB-EGF (Heparin Binding EGF) |
||
| Z102159 | 1.0 mg | EUR 750 |
|
Description: Human HBEGF (Heparin Binding EGF like growth factor) is a member of the EGF family of peptide growth factors that signal through the EGF receptor, and stimulates the proliferation of smooth muscle cells, fibroblasts, epithelial cells, and keratinocytes. HBEGF is expressed in many cell types and tissues, including bronchial epithelium, visceral and vascular smooth muscle, CD4+ T cells, glomerular podocytes, keratinocytes, macrophages and certain tumor cells. Mature HBEGF is a soluble peptide that arises from the proteolytic processing of the 208 amino acid type-I transmembrane form and exhibits the ability to specifically bind heparin and heparin sulfate proteoglycans. |
||
Recombinant Human HB-EGF (Heparin Binding EGF) |
||
| MBS4159826-005mg | 0.05mg | EUR 230 |
Recombinant Human HB-EGF (Heparin Binding EGF) |
||
| MBS4159826-02mg | 0.2mg | EUR 390 |
Recombinant Human HB-EGF (Heparin Binding EGF) |
||
| MBS4159826-1mg | 1mg | EUR 985 |
Recombinant Human HB-EGF (Heparin Binding EGF) |
||
| MBS4159826-5x1mg | 5x1mg | EUR 4180 |
Human CellExp? EGF, human recombinant |
||
| 7228-10 | each | EUR 352.8 |
EGF Receptor, human recombinant |
||
| 7135-10 | each | EUR 280.8 |
EGF Receptor, human recombinant |
||
| 7135-50 | each | EUR 1032 |
Recombinant Human EGF, Fc tagged |
||
| MK0235H | 10ug | EUR 319.2 |
|
Description: Fc |
||
Recombinant Human EGF, GST-tagged |
||
| EGF-12320H | 25ug | EUR 255.2 |
|
Description: The protein is stored in PBS buffer at -20℃. Avoid repeated freezing and thawing cycles. |
||
Recombinant Human EGF-L7 Protein |
||
| PROTQ9UHF1 | 10ug | EUR 380.4 |
|
Description: EGF-L7 (Epidermal Growth Factor Like Protein 7, Multiple EGF Like Domains Protein 7, VE Statin) is a multi-domain protein containing two EGF like domains and one EMI domain. It is expressed almost exclusively in endothelial cells and functions to promote normal development of the vascular system, particularly tubulogenesis. EGF-L7 is capable of antagonistic binding to Notch receptors resulting in the inhibition of Notch signaling in HUVEC and neural stem cells. In research models inducing hypoxia and subsequent reoxygenation, (H/R), EGF-L7 can inhibit ICAM-1 expression and enhance the inhibition of NF-kappaB activation. Additionally, EGF-L7 can chemoattract endothelial cells and bind to the extracellular matrix. The overexpression of EGF-L7 is observed in various cancers, and is generally correlated with increased metastasis and a poor prognosis. Recombinant human EGF-L7 is a 28 kDa protein containing 251 amino acid residues. |
||
Active Recombinant Human EGF Protein |
||
| RP01030 | 20 μg | EUR 26 |
Active Recombinant Human EGF Protein |
||
| RP01502 | 10μg | EUR 104 |
Recombinant Human EGF Protein (Active) |
||
| PKSH033687-100ug | 100ug | EUR 98 |
|
Description: Human |
||
Recombinant Human EGF Protein (Active) |
||
| PKSH033687-500ug | 500ug | EUR 249 |
|
Description: Human |
||
Recombinant Human EGF Protein (Active) |
||
| PKSH031641-100ug | 100ug | EUR 127 |
|
Description: Human |
||
Recombinant Human EGF Protein (Active) |
||
| PKSH031641-1mg | 1mg | EUR 420 |
|
Description: Human |
||
Purified recombinant Human EGF protein |
||
| MBS5308621-01mg | 0.1mg | EUR 1555 |
Purified recombinant Human EGF protein |
||
| MBS5308621-5x01mg | 5x0.1mg | EUR 6955 |
Recombinant Human EGF Receptor (EGFR) Protein |
||
| PROTP00533-3 | 10ug | EUR 380.4 |
|
Description: EGF Receptor (EGFR, ErbB1) is a transmembrane protein that exerts tyrosine kinase activity upon ligand induced activation. EGFR can be activated by binding EGF or at least six other structurally related protein ligands, including TGFα, HB-EGF, Betacellulin (BTC), Amphiregulin, Epiregulin, and Epigen. Upon activation, EGFR initiates a signaling cascade which includes dimerization and internalization, tyrosine phosphorylation, DNA synthesis of target genes, and, ultimately, cell proliferation. EGFR signaling plays a role in the growth and differentiation of normal cells, but elevated EGFR activity is correlated with the development and pathogenesis of certain cancers. Recombinant soluble human EGFR is a 621 amino acid glycoprotein comprising the extracellular domain of EGFR, and migrates at an apparent MW of 97.5 kDa by SDS-PAGE analysis under reducing conditions. |
||
EGF Protein, Human, Recombinant (ECD) |
||
| MBS8118644-01mg | 0.1mg | EUR 160 |
EGF Protein, Human, Recombinant (ECD) |
||
| MBS8118644-1mg | 1mg | EUR 305 |
EGF Protein, Human, Recombinant (ECD) |
||
| MBS8118644-5x1mg | 5x1mg | EUR 1215 |
Recombinant Human EGF Protein, No Tag |
||
| E40KMH1011 | 20ug | EUR 495 |
Recombinant Human EGF Protein, His Tag |
||
| E40KMH566 | 20ug | EUR 495 |
Human EGF Recombinant Protein Lyophilized |
||
| IHUEGFRLY100UG | each | EUR 341 |
|
Description: Human EGF Recombinant Protein Lyophilized |
||
Human EGF Recombinant Protein Lyophilized |
||
| MBS8431898-INQUIRE | INQUIRE | Ask for price |
Recombinant Human EGF protein, GMP Grade |
||
| EGF-830THP | 10ug | EUR 798.4 |
|
Description: Protein |
||
Recombinant Human EGF protein, GMP Grade |
||
| EGF-832THP | 10ug | EUR 798.4 |
|
Description: Protein |
||
Genorise® recombinant human EGF protein |
||
| GR119159 | 10 µg | EUR 193 |
Recombinant Human EGF Protein, low endotoxin |
||
| EPLE-06H | 50ug | EUR 351.2 |
|
Description: Human |
||
Recombinant Human EGF Protein (Asn971-Arg1023) |
||
| MK0242H | 10ug | EUR 319.2 |
|
Description: N/A |
||
Human EGF(Animal Free) Recombinant Protein |
||
| 100-008-AF | 100 µg | EUR 134.4 |
|
Description: EGF is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-α and VGF (vaccinia virus growth factor). Recombinant Human EGF is a 6.2 kDa globular protein containing 53 amino acid residues, including 3 intramolecular disulfide bonds. |
||
Human EGF(Animal Free) Recombinant Protein |
||
| 100-009-AF | 500 µg | EUR 229.95 |
|
Description: EGF is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-α and VGF (vaccinia virus growth factor). Recombinant Human EGF is a 6.2 kDa globular protein containing 53 amino acid residues, including 3 intramolecular disulfide bonds. |
||
Recombinant Human EGF Protein, Fc & His Tag |
||
| E40KMP1438 | 20ug | EUR 495 |
Recombinant Human EGF protein, N- His Tag |
||
| MBS157687-005mg | 0.05mg | EUR 320 |
Recombinant Human EGF protein, N- His Tag |
||
| MBS157687-01mg | 0.1mg | EUR 410 |
Recombinant Human EGF protein, N- His Tag |
||
| MBS157687-1mg | 1mg | EUR 1870 |
Recombinant Human EGF protein, N- His Tag |
||
| MBS157687-5x1mg | 5x1mg | EUR 8090 |
Recombinant Human EGF protein, C-His Tag |
||
| MBS157206-005mg | 0.05mg | EUR 320 |
Recombinant Human EGF protein, C-His Tag |
||
| MBS157206-01mg | 0.1mg | EUR 410 |
Recombinant Human EGF protein, C-His Tag |
||
| MBS157206-5x01mg | 5x0.1mg | EUR 1520 |
Recombinant Human EGF protein, C-His Tag |
||
| MBS1560444-005mg | 0.05mg | EUR 320 |
Recombinant Human EGF protein, C-His Tag |
||
| MBS1560444-01mg | 0.1mg | EUR 410 |
Recombinant Human EGF protein, C-His Tag |
||
| MBS1560444-1mg | 1mg | EUR 1870 |
Recombinant Human EGF protein, C-His Tag |
||
| MBS1560444-5x1mg | 5x1mg | EUR 8090 |
Recombinant Human Epidermal Growth Factor/EGF |
||
| AP74788 | 1mg | EUR 329 |
Recombinant Human Epidermal Growth Factor/EGF |
||
| C029-10ug | 10ug | EUR 84 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, pH 7.0. |
||
Recombinant Human Epidermal Growth Factor/EGF |
||
| C029-1mg | 1mg | EUR 230.4 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, pH 7.0. |
||
Recombinant Human Epidermal Growth Factor/EGF |
||
| C029-500ug | 500ug | EUR 178.8 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, pH 7.0. |
||
Recombinant Human Epidermal Growth Factor/EGF |
||
| C029-50ug | 50ug | EUR 120 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, pH 7.0. |
||
Recombinant Human EGF Protein (Fc Tag)(Active) |
||
| PKSH032002-100ug | 100ug | EUR 127 |
|
Description: Human |
||
Human EGF-L7 Recombinant Protein Lyophilized |
||
| IHUEGFL7RLY10UG | each | EUR 317 |
|
Description: Human EGF-L7 Recombinant Protein Lyophilized |
||
Human EGF-L7 Recombinant Protein Lyophilized |
||
| IHUEGFL7RLY2UG | each | EUR 317 |
|
Description: Human EGF-L7 Recombinant Protein Lyophilized |
||
Human EGF-L7 Recombinant Protein Lyophilized |
||
| MBS8431891-INQUIRE | INQUIRE | Ask for price |
Human EGF-L7 Recombinant Protein Lyophilized |
||
| MBS8431892-INQUIRE | INQUIRE | Ask for price |
Recombinant Human EGF Like Domain Multiple 6 |
||
| cyt-974-100g | 100µg | EUR 700 |
Recombinant Human EGF Like Domain Multiple 6 |
||
| cyt-974-10g | 10µg | EUR 145 |
Recombinant Human EGF Like Domain Multiple 6 |
||
| cyt-974-2g | 2µg | EUR 60 |
Recombinant Human EGF Like Domain Multiple 6 |
||
| MBS146746-0002mg | 0.002mg | EUR 240 |
Recombinant Human EGF Like Domain Multiple 6 |
||
| MBS146746-001mg | 0.01mg | EUR 310 |
Recombinant Human EGF Like Domain Multiple 6 |
||
| MBS146746-01mg | 0.1mg | EUR 860 |
Recombinant Human EGF Like Domain Multiple 6 |
||
| MBS146746-5x01mg | 5x0.1mg | EUR 3540 |
Human EGF receptor Recombinant Protein Lyophilized |
||
| IHUEGFRRLY2UG | each | EUR 341 |
|
Description: Human EGF receptor Recombinant Protein Lyophilized |
||
Human EGF receptor Recombinant Protein Lyophilized |
||
| MBS8431903-INQUIRE | INQUIRE | Ask for price |
Epidermal Growth Factor (EGF), human recombinant |
||
| 4022-100 | each | EUR 176.4 |
Epidermal Growth Factor (EGF), human recombinant |
||
| 4022-1000 | each | EUR 424.8 |
Epidermal Growth Factor (EGF), human recombinant |
||
| 4022-500 | each | EUR 320.4 |
Epidermal Growth Factor (EGF), human recombinant |
||
| 4022-5000 | each | EUR 1358.4 |
Epidermal Growth Factor (EGF) human (RECOMBINANT) |
||
| GF-010-5 | 100ug | EUR 80 |
Epidermal Growth Factor (EGF) human (RECOMBINANT) |
||
| GF-010-8 | 500ug | EUR 250 |
Epidermal Growth Factor (EGF) human (RECOMBINANT) |
||
| GF-010-9 | 1mg | EUR 450 |
Epidermal Growth Factor (EGF), human recombinant |
||
| P1008-.1 | 100 µg | EUR 134 |
|
Description: EGF, expressed in E.Coli, His-tag, suitable for cell culture. |
||
Epidermal Growth Factor (EGF), human recombinant |
||
| P1008-.5 | 500 µg | EUR 317 |
|
Description: EGF, expressed in E.Coli, His-tag, suitable for cell culture. |
||
Epidermal Growth Factor (EGF), human recombinant |
||
| P1008-1 | 1 mg | EUR 416 |
|
Description: EGF, expressed in E.Coli, His-tag, suitable for cell culture. |
||
Epidermal Growth Factor (EGF), human recombinant |
||
| P1008-5 | 5 mg | EUR 1580 |
|
Description: EGF, expressed in E.Coli, His-tag, suitable for cell culture. |
||
Recombinant Human EGF Protein (aa 971-1023) [Fc] |
||
| VAng-Cr3970-100g | 100 µg | EUR 355.2 |
|
Description: Recombinant Human EGF Protein (Asn 971-Arg 1023) fused with a Fc tag at N-terminus was expressed in HEK293 Cells, with a molecular weight of 33 kDa. (Accession ID: NP_001954.2) |
||
Recombinant Human EGF Protein (aa 971-1023) [Fc] |
||
| VAng-Cr3970-1mg | 1 mg | EUR 963.6 |
|
Description: Recombinant Human EGF Protein (Asn 971-Arg 1023) fused with a Fc tag at N-terminus was expressed in HEK293 Cells, with a molecular weight of 33 kDa. (Accession ID: NP_001954.2) |
||
Recombinant Human EGF Protein (Asn 971 - Arg 1023) |
||
| MK0240H | 10ug | EUR 319.2 |
|
Description: N/A |
||